The Food and Drug Administration USA approved a new Drug Opvido to be used in Advanced non small cell lung cancer.
Lung Cancer is the leading cause of Death in America
SIt's estimated that there were more than 224,000 new cases of lung cancer in America resulting in more than 160,000 deaths in 2014..
Opvido Blocks the proteins that inhibit immune cells from attacking cancer cells
The drug acts by inhibiting a protein that prevent immune cells from attacking cancer cells.
Side effects include fatigue and shortness of breath
The most common side effects include fatigue, shortness of breath, musculoskeletal pain, decreased appetite, cough, nausea, and constipation.